Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
FranceA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
FranceStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
FranceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
FranceA study of rilvegostomig and ramucirumab in patients with advanced or metastatic non-small cell lung cancer
FranceComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
FranceA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
FranceA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
FranceA study of ACR-368 and gemcitabine for patients with endometrial cancer
FranceA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
FranceA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
FranceStudy of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
